Physician profile
Peter M Brier
NPI 1952392367
$1,574.94
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,249 · 2020: $201 · 2021: $125.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $421.62 | 2019-2021 | |
| Novo Nordisk INC | $209.40 | 2019-2020 | |
| Lilly USA, LLC | $129.45 | 2019 | |
| Boston Scientific Corporation | $90.98 | 2019 | |
| Merck Sharp & Dohme LLC | $80.07 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $79.74 | 2019 | |
| Sanofi Pasteur INC. | $61.05 | 2019 | |
| Amarin Pharma, INC. | $55.38 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $55.15 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $52.08 | 2019-2020 | |
| Pfizer INC. | $50.74 | 2019-2020 | |
| Biofire Diagnostics, LLC | $48.41 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $38.78 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $35.50 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.02 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $33.87 | 2019 | |
| Glaxosmithkline, LLC. | $28.90 | 2019-2020 | |
| Astellas Pharma US INC | $24.95 | 2020 | |
| Strongbridge US INC. | $19.50 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.23 | 2019 | |
| Ironshore Pharmaceuticals INC. | $12.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Brier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.